334 related articles for article (PubMed ID: 16938813)
1. Radiation dose to laterally transposed ovaries during external beam radiotherapy for cervical cancer.
Mazonakis M; Damilakis J; Varveris H; Gourtsoyiannis N
Acta Oncol; 2006; 45(6):702-7. PubMed ID: 16938813
[TBL] [Abstract][Full Text] [Related]
2. Radiation dose to testes and risk of infertility from radiotherapy for rectal cancer.
Mazonakis M; Damilakis J; Varveris H; Gourtsouiannis N
Oncol Rep; 2006 Mar; 15(3):729-33. PubMed ID: 16465437
[TBL] [Abstract][Full Text] [Related]
3. Scattered dose to gonads and associated risks from radiotherapy for common pediatric malignancies : a phantom study.
Mazonakis M; Zacharopoulou F; Kachris S; Varveris C; Damilakis J; Gourtsoyiannis N
Strahlenther Onkol; 2007 Jun; 183(6):332-7. PubMed ID: 17520188
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of transposition of the ovaries in the surgical and radiotherapeutical treatment of cervical cancer.
van Beurden M; Schuster-Uitterhoeve AL; Lammes FB
Eur J Surg Oncol; 1990 Apr; 16(2):141-6. PubMed ID: 2323410
[TBL] [Abstract][Full Text] [Related]
5. [Transposed ovarian function conservation in cervical cancer patients with radiotherapy].
Wu XH; Li ZT; Huang X; Zhou YQ; Cheng X; Cai SM; Zhang ZY
Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):220-2. PubMed ID: 15924664
[TBL] [Abstract][Full Text] [Related]
6. Risk estimation of radiation-induced thyroid cancer from treatment of brain tumors in adults and children.
Mazonakis M; Damilakis J; Varveris H; Fasoulaki M; Gourtsoyiannis N
Int J Oncol; 2003 Jan; 22(1):221-5. PubMed ID: 12469208
[TBL] [Abstract][Full Text] [Related]
7. Association between the location of transposed ovary and ovarian dose in patients with cervical cancer treated with postoperative pelvic radiotherapy.
Lv XJ; Cheng XL; Tu YQ; Yan DD; Tang Q
Radiat Oncol; 2019 Dec; 14(1):230. PubMed ID: 31842971
[TBL] [Abstract][Full Text] [Related]
8. [Dosimetric analysis of radiotherapy with middle shielding blocks of different widths at the lower cervical supraclavicular field for stage N2-3 nasopharyngeal carcinoma].
Li FM; Luo W; He ZC; Zhang L; Sun Y; Qin WJ; Lu LX; Han F; Liu XQ; Liu MZ
Ai Zheng; 2007 Oct; 26(10):1127-32. PubMed ID: 17927886
[TBL] [Abstract][Full Text] [Related]
9. Predicting age of ovarian failure after radiation to a field that includes the ovaries.
Wallace WH; Thomson AB; Saran F; Kelsey TW
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):738-44. PubMed ID: 15936554
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of transposed ovarian function in young women with cervical cancer].
Wang JL; Zhang XH; Liang XD; Wang SJ; Xing HM; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):229-32. PubMed ID: 16759455
[TBL] [Abstract][Full Text] [Related]
11. [Radiation dose in critical organs due to non-coplanar irradiation of the hypophysis].
Schulte RW; Rittmann KL; Meinass HJ; Rennicke P
Strahlenther Onkol; 1996 Sep; 172(9):501-6. PubMed ID: 8928057
[TBL] [Abstract][Full Text] [Related]
12. Effect of intensity-modulated pelvic radiotherapy on second cancer risk in the postoperative treatment of endometrial and cervical cancer.
Zwahlen DR; Ruben JD; Jones P; Gagliardi F; Millar JL; Schneider U
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):539-45. PubMed ID: 19427555
[TBL] [Abstract][Full Text] [Related]
13. Dose estimation in postoperative keloid irradiation with special consideration of ovarian dose.
Schmidt WF; Hohenberg G; Handl-Zeller L
Strahlenther Onkol; 1991 Sep; 167(9):534-7. PubMed ID: 1925937
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy for supradiaphragmatic Hodgkin's disease: determination of the proper fetal shielding conditions using Monte Carlo methodology.
Mazonakis M; Tzedakis A; Varveris C; Damilakis J
Phys Med; 2011 Oct; 27(4):181-7. PubMed ID: 21216645
[TBL] [Abstract][Full Text] [Related]
15. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
Beriwal S; Bhatnagar A; Heron DE; Selvaraj R; Mogus R; Kim H; Gerszten K; Kelley J; Edwards RP
Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer.
Mell LK; Tiryaki H; Ahn KH; Mundt AJ; Roeske JC; Aydogan B
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1504-10. PubMed ID: 18640499
[TBL] [Abstract][Full Text] [Related]
17. High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes.
Kim YS; Kim JH; Ahn SD; Lee SW; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1522-8. PubMed ID: 19231106
[TBL] [Abstract][Full Text] [Related]
18. A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors.
Palm A; Johansson KA
Acta Oncol; 2007; 46(4):462-73. PubMed ID: 17497313
[TBL] [Abstract][Full Text] [Related]
19. [Dosimetry of lower segment irradiation in Hodgkin disease. II. Radiation burden of risk organs].
Dorsch G; Sauer R; Müller RG
Strahlentherapie; 1984 Sep; 160(9):527-34. PubMed ID: 6437019
[TBL] [Abstract][Full Text] [Related]
20. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.
Dimopoulos JC; Lang S; Kirisits C; Fidarova EF; Berger D; Georg P; Dörr W; Pötter R
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):56-63. PubMed ID: 19289267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
